69.08

2.28% -1.6718

Inspire Medical Systems Inc (INSP)

Overview News Price History Option Chain Financials Why INSP Down? Discussions Forecast

Inspire Medical Systems Inc stock is traded at $69.08, with a volume of 107.12K. It is down -2.28% in the last 24 hours and up +9.60% over the past month. Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

Previous Close:

$70.75

Open:

$71.23

24h Volume:

107.12K

Relative Volume:

0.13

Market Cap:

$1.99B

Revenue:

$915.25M

Net Income/Loss:

$131.14M

P/E Ratio:

15.45

EPS:

4.472

Net Cash Flow:

$96.71M

1W Performance:

-5.53%

1M Performance:

+9.60%

6M Performance:

+27.70%

1Y Performance:

-9.47%

1-Day Range:

$68.64

$71.86

1-Week Range:

$68.44

$75.31

52-Week Range:

$38.91

$147.03

Inspire Medical Systems Inc Stock (INSP) Company Profile

Name

Inspire Medical Systems Inc

Sector

Healthcare (1072)

Industry

Medical Devices (137)

Phone

763-957-5037

Address

5500 WAYZATA BLVD, GOLDEN VALLEY

Employee

1,333

Twitter

@inspiresleep

Next Earnings Date

2026-11-02

Latest SEC Filings

INSP's Discussions on Twitter

Compare INSP vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INSP Inspire Medical Systems Inc	68.77	2.04B	915.25M	131.14M	96.71M	4.472
ABT Abbott Laboratories	99.25	168.71B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	87.61	110.49B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	281.07	105.65B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	42.42	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	87.38	49.74B	6.30B	1.07B	1.09B	1.8406

Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-13-26	Downgrade	Wolfe Research	Outperform → Peer Perform
Feb-12-26	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-12-26	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-27-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jan-22-26	Downgrade	Oppenheimer	Outperform → Perform
Jan-22-26	Downgrade	Truist	Buy → Hold
Dec-08-25	Upgrade	Oppenheimer	Perform → Outperform
Dec-02-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-26-25	Upgrade	Truist	Hold → Buy
Nov-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform
Nov-24-25	Upgrade	Stifel	Hold → Buy
Nov-04-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-24-25	Downgrade	Jefferies	Buy → Hold
Sep-22-25	Downgrade	UBS	Buy → Neutral
Sep-02-25	Initiated	Evercore ISI	Outperform
Aug-05-25	Downgrade	JP Morgan	Overweight → Neutral
Aug-05-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Aug-05-25	Downgrade	Truist	Buy → Hold
Nov-20-24	Upgrade	BofA Securities	Neutral → Buy
May-08-24	Downgrade	BofA Securities	Buy → Neutral
Apr-19-24	Initiated	RBC Capital Mkts	Outperform
Mar-19-24	Initiated	Morgan Stanley	Overweight
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight
Jan-19-24	Initiated	Jefferies	Buy
Jan-02-24	Downgrade	Stifel	Buy → Hold
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Apr-14-23	Initiated	Mizuho	Buy
Mar-29-23	Initiated	UBS	Buy
Dec-13-22	Upgrade	Goldman	Neutral → Buy
Dec-13-22	Initiated	KeyBanc Capital Markets	Overweight
Apr-13-22	Initiated	Truist	Buy
Apr-06-22	Initiated	Wolfe Research	Peer Perform
Mar-02-22	Resumed	BofA Securities	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Nov-03-20	Upgrade	BofA Securities	Neutral → Buy
Nov-03-20	Upgrade	Oppenheimer	Underperform → Perform
Sep-22-20	Initiated	JP Morgan	Overweight
Sep-02-20	Initiated	Robert W. Baird	Outperform
Aug-06-20	Downgrade	BofA Securities	Buy → Neutral
Jul-15-20	Initiated	Goldman	Buy
Jun-18-20	Reiterated	Piper Sandler	Overweight
May-18-20	Initiated	Lake Street	Buy
Apr-28-20	Upgrade	BofA/Merrill	Neutral → Buy
Apr-09-20	Initiated	Piper Sandler	Overweight
Jan-28-20	Initiated	Oppenheimer	Underperform
Jan-27-20	Initiated	Oppenheimer	Underperform
Nov-06-19	Upgrade	Berenberg	Sell → Hold
Feb-05-19	Initiated	Dougherty & Company	Buy
Nov-28-18	Initiated	Berenberg	Sell
Oct-29-18	Initiated	Leerink Partners	Outperform
May-29-18	Initiated	Guggenheim	Buy
May-29-18	Initiated	Stifel	Buy
May-29-18	Initiated	Wells Fargo	Outperform

View All

Inspire Medical Systems Inc Stock (INSP) Latest News

Oct 01, 2026

Inspire Medical Systems (INSP) Gains CPT Code Approval for Inspi - GuruFocus

Oct 01, 2026

Inspire Medical receives new CPT codes for sleep apnea device By Investing.com - Investing.com UK

Oct 01, 2026

More than 140,000 patients have been treated for sleep apnea with Inspire. New billing codes are scheduled for 2028. - Stock Titan

Oct 01, 2026

Inspire Medical Systems Jumps 5.4% After RBC Capital Maintains Sector Perform - AlphaStreet

Oct 01, 2026

RBC Raises Price Target on Inspire Medical Systems to $75 From $60, Keeps Sector Perform Rating - marketscreener.com

Oct 01, 2026